Director of Sarwal Lab, UCSF
Dr. Minnie M. Sarwal is Professor of Surgery and Director of the Sarwal Lab at UCSF. Dr. Sarwal is a nationally and internationally recognized leader in the fields of renal and transplant medicine, genomics, proteomics and immunology. She has a deep passion for improving the health of organ transplant recipients by discovering new treatments and investigative approaches for improving outcomes. She is on the Science Board for the FDA and on faculty for the Masters in Translational Medicine program, a joint program w UCSF and the Haas School of Business, University of California, Berkekey. She was previously Professor of Pediatrics and Surgery and Director of the Pediatric Kidney Transplant Program at Stanford University. Dr. Sarwal Founded Organ-i in 2009. The company’s goal is to improve the clinical management of transplant patients globally by commercializing non-invasive tests to monitor and predict organ health for transplant recipients. She developed Organ-i’s first product, the kidney Solid Organ Rejection Test (k-SORT), as well as a pipeline of molecular assays focused on post-transplant rejection monitoring and allograft tolerance. In June 2014. Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced the acquisition of Organ-i and retained Dr. Sarwal as a scientific advisory role to advance the Organ-i pipeline.